Shell settles with EPA to install $10M in emissions equipment in Louisiana

UPI Top Stories |

As part of a settlement with the Environmental Protection Agency and Justice Department on Monday, energy giant Shell agreed to install $10 million in pollution monitoring and control equipment at its Norco, La., plant in St. Charles Parish.

Installing the equipment would help reduce harmful air pollution from four industrial flares at the plant, the Justice Department said.

Once in place, the pollution controls are estimated to reduce air emissions of volatile organic compounds, or VOCs, by about 159 tons per year and reduce benzene by about 18 tons per year.

VOCs are a key element in the formation of ground-level ozone, which can irritate the lungs and exacerbate asthma and increase susceptibility to pneumonia and bronchitis. The EPA classifies benzene as a carcinogen, and says chronic exposure to the pollutant can cause leukemia and adverse reproductive effects in women.

"This settlement will improve air quality for citizens of Louisiana by reducing emissions of harmful air pollution," said Scott Pruitt, EPA administrator. "Today's agreement demonstrates EPA's dedication to working with states to pursue violations of laws that are critical to protecting public health and bring companies into compliance."

Chuck Carr Brown, Louisiana Department of Environmental Quality secretary, said the department is committed to working hand-in-hand with federal partners to reduce air pollution in Louisiana.

"Actions like this one not only serve to clean up the air our citizens breathe, they send a message that we will not tolerate violations of federal or state laws," Brown said.

Under the agreement, Shell will take steps to minimize the amount of waste gas sent to the flares and operate a flare gas recovery system, which allows the company to use the waste gas as fuel instead of it being sent to the facility's flares.

Shell also agreed to install and maintain monitoring equipment to detect air pollution and publish the results on a public website, and pay $350,000 in civil penalties including $87,500 to the Louisiana Department of Environmental Quality.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.